Baker Biotech Capital II (Z) (GP), LLC Insider Trading $SGEN Seagen Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Baker Biotech Capital II (Z) (GP), LLC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Baker Biotech Capital II (Z) (GP), LLC. Baker Biotech Capital II (Z) (GP), LLC is 10% Owner in VIROPHARMA INC ($VPHM) and 10% Owner in Ardea Biosciences, Inc./DE ($IBPI) and Director in SEATTLE GENETICS INC /WA ($SGEN).
Baker Biotech Capital II (Z) (GP), LLC in Seagen Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Baker Biotech Capital II (Z) (GP), LLC: Director
Holdings: 49,807 shares
Current Value: $3,027,768
Latest Transaction: May 06 2005
$SGEN Market Capitalization: $8.71B
$SGEN Previous Close: $60.79
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Baker Biotech Capital II (Z) (GP), LLC in Seagen Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IBPI, SGEN, VPHM
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 06 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.79 | 948 | 4,541 | 49,807 | 48.9 K to 49.8 K (+1.94 %) |
| Apr 01 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.96 | 1,506 | 7,474 | 37,317 | 35.8 K to 37.3 K (+4.21 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.90 | 826 | 4,047 | 35,811 | 35 K to 35.8 K (+2.36 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.81 | 346 | 1,666 | 34,985 | 34.6 K to 35 K (+1.00 %) |
| Mar 30 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.90 | 113 | 554 | 34,639 | 34.5 K to 34.6 K (+0.33 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.96 | 9,919 | 49,193 | 34,526 | 24.6 K to 34.5 K (+40.31 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.99 | 7 | 35 | 24,607 | 24.6 K to 24.6 K (+0.03 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 5.04 | 10,329 | 52,024 | 24,600 | 14.3 K to 24.6 K (+72.38 %) |
| Mar 24 2005 | SGEN | SEATTLE GENETICS I ... | Baker Biotech Capital II (Z) ( ... | Director | Buy | P | 4.88 | 729 | 3,557 | 14,271 | 13.5 K to 14.3 K (+5.38 %) |
Page: 1